# Interferon-gamma With Interferon Alpha and Ribavirin for Hepatitis C Non-responders

> **NCT00538811** · PHASE2,PHASE3 · COMPLETED · sponsor: **Aga Khan University** · enrollment: 40 (estimated)

## Conditions studied

- Hepatitis C
- Genotype 3
- Non-responders
- Relapsers

## Interventions

- **DRUG:** interferon alpha-2b, ribavirin, interferon-gamma,
- **DRUG:** interferon alpha-2b, ribavirin, amantadine

## Key facts

- **NCT ID:** NCT00538811
- **Lead sponsor:** Aga Khan University
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2010-10-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00538811

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00538811, "Interferon-gamma With Interferon Alpha and Ribavirin for Hepatitis C Non-responders". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT00538811. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*